Fasenra

Fasenra (Benralizumab) is a subcutaneous injection used for managing asthma symptoms. This medication targets specific cells to help reduce inflammation in the airways, offering relief for certain types of asthma.

Fasenra is primarily used for the maintenance treatment of severe eosinophilic asthma in adults and pediatric patients. It works by targeting and reducing eosinophils, a type of white blood cell involved in asthma inflammation. Patients often wonder, 'What is Fasenra used for?'—it's designed to help control asthma symptoms and reduce the need for oral corticosteroids.

Common effects of Fasenra may include reactions at the injection site, such as redness, swelling, or itching. Some patients might experience headaches or fatigue. These effects are generally mild and temporary, but it's important to monitor any persistent or severe reactions.

Fasenra should be administered under the supervision of a healthcare provider. Patients with a history of severe hypersensitivity to Benralizumab or any of its components should avoid using this medication. Always follow the prescribed guidelines for storage and administration to ensure safety.

Fasenra may interact with other medications, particularly those that affect the immune system. It's important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods might also influence its effectiveness.